We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+9.14%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$6.45B
AUM Growth
+$5.8M
Cap. Flow
-$487M
Cap. Flow %
-7.55%
Top 10 Hldgs %
17.51%
Holding
879
New
59
Increased
152
Reduced
496
Closed
61

Top Buys

Rank Stock Value
1
PH icon
Parker-Hannifin
PH
+$16.8M
2
PWR icon
Quanta Services
PWR
+$16.7M
3
HAS icon
Hasbro
HAS
+$16.3M
4
NXPI icon
NXP Semiconductors
NXPI
+$14.7M
5
RRX icon
Regal Rexnord
RRX
+$13.5M

Sector Composition

Rank Sector Weight
1 Technology 19.42%
2 Healthcare 16.47%
3 Financials 13.82%
4 Industrials 10.74%
5 Consumer Discretionary 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLP icon
676
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
$443K 0.01%
7,015
CHKP icon
677
Check Point Software Technologies
CHKP
$14.3B
$438K 0.01%
3,939
TRNO icon
678
Terreno Realty
TRNO
$7.58B
$437K 0.01%
8,079
-602
-7% -$32.9K
SPLV icon
679
Invesco S&P 500 Low Volatility ETF
SPLV
$7.24B
$430K 0.01%
7,371
-426
-5% -$24.4K
ZD icon
680
Ziff Davis
ZD
$2B
$426K 0.01%
5,233
D icon
681
Dominion Energy
D
$62.1B
$423K 0.01%
5,120
PYPL icon
682
PayPal
PYPL
$49.9B
$423K 0.01%
3,903
-322
-8% -$33.6K
MIND icon
683
MIND Technology
MIND
$43.4M
$421K 0.01%
+14,676
New +$366K
KMT icon
684
Kennametal
KMT
$2.56B
$419K 0.01%
11,343
-43
-0.4% -$1.44K
TPTX
685
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$419K 0.01%
+6,715
New +$320K
REGN icon
686
Regeneron Pharmaceuticals
REGN
$72.9B
$418K 0.01%
1,110
+13
+1% +$4.37K
CASY icon
687
Casey's General Stores
CASY
$32.1B
$407K 0.01%
2,561
SCHD icon
688
Schwab US Dividend Equity ETF
SCHD
$104B
$406K 0.01%
21,078
-1,005
-5% -$18.8K
TSLA icon
689
Tesla
TSLA
$1.18T
$398K 0.01%
14,295
-4,455
-24% -$96.6K
DXCM icon
690
DexCom
DXCM
$29B
$394K 0.01%
7,200
-1,880
-21% -$89.2K
OGE icon
691
OGE Energy
OGE
$9.87B
$394K 0.01%
8,840
ACHC icon
692
Acadia Healthcare
ACHC
$2.55B
$392K 0.01%
11,789
DVA icon
693
DaVita
DVA
$15.5B
$391K 0.01%
5,190
SHAK icon
694
Shake Shack
SHAK
$2.54B
$391K 0.01%
+6,554
New +$471K
ETR icon
695
Entergy
ETR
$50.3B
$387K 0.01%
6,452
-24
-0.4% -$1.41K
WTRG icon
696
Essential Utilities
WTRG
$11.5B
$386K 0.01%
8,242
-1,875
-19% -$84.4K
WU icon
697
Western Union
WU
$2.53B
$385K 0.01%
14,400
-3,200
-18% -$83K
PPG icon
698
PPG Industries
PPG
$24.9B
$384K 0.01%
2,871
-258
-8% -$32.7K
OXY icon
699
Occidental Petroleum
OXY
$55.7B
$382K 0.01%
9,253
-7,790
-46% -$312K
XLNX
700
DELISTED
Xilinx Inc
XLNX
$382K 0.01%
3,912
+2
+0.1% +$188

Similar funds

Segall Bryant & Hamill's Q4 2019 Portfolio in Review

As of Q4 2019, Segall Bryant & Hamill held 879 positions worth $6.45B, up 0.09% from $6.44B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Segall Bryant & Hamill withdrew a net $487M in Q4 2019, closing 61 positions and reducing 496 holdings. Its most notable exit was Avista, an estimated $21.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Segall Bryant & Hamill opened a new position in NexTier Oilfield Solutions Inc. worth $11.3M.

  • Segall Bryant & Hamill's largest Q4 2019 buy was NexTier Oilfield Solutions Inc.: 1,680,626 shares worth $11.3M.
  • Segall Bryant & Hamill added most to Parker-Hannifin in Q4 2019, an estimated $16.8M increase.
  • Segall Bryant & Hamill's biggest Q4 2019 reduction was iShares Russell 2000 Value ETF, cutting an estimated $19.6M.
  • Segall Bryant & Hamill fully exited Avista in Q4 2019, selling an estimated $21.6M.
  • Segall Bryant & Hamill's ten largest holdings make up 18% of its $6.45B portfolio in Q4 2019.
  • Segall Bryant & Hamill opened 59 new positions and closed 61 in Q4 2019.
  • Segall Bryant & Hamill's portfolio value rose 0.09% quarter-over-quarter to $6.45B.

Based on Segall Bryant & Hamill's 13F filing for Q4 2019, filed 11 Feb 2020.